These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26226362)

  • 1. Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging.
    Covington MF; Sherman S; Lewis D; Lei H; Krupinski E; Kuo PH
    PLoS One; 2015; 10(7):e0134457. PubMed ID: 26226362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.
    Graebner AK; Tarsy D; Shih LC; Vanderhorst V; Kulkarni O; Kaplan S; Simon DK
    Neurodegener Dis; 2017; 17(1):38-43. PubMed ID: 27614874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
    Bajaj N; Hauser RA; Grachev ID
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1288-95. PubMed ID: 23486993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Overview of
    Mercer MK; Revels JW; Blacklock LC; Banks KP; Johnson LS; Lewis DH; Kuo PH; Wilson S; Elojeimy S
    Radiographics; 2024 Feb; 44(2):e230133. PubMed ID: 38236751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.
    Tolosa E; Borght TV; Moreno E;
    Mov Disord; 2007 Dec; 22(16):2346-51. PubMed ID: 17914722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the Diagnosis of Parkinsonian Syndromes With
    Banks KP; Peacock JG; Clemenshaw MN; Kuo PH
    AJR Am J Roentgenol; 2019 Aug; 213(2):243-253. PubMed ID: 30995085
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.
    Isaacson SH; Fisher S; Gupta F; Hermanowicz N; Kremens DE; Lew MF; Marek K; Pahwa R; Russell DS; Seibyl J
    Expert Rev Neurother; 2017 Mar; 17(3):219-225. PubMed ID: 27813429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The usefulness of SPECT with 123I-ioflupane (DaTSCAN) in Parkinsonism induced by pharmaceuticals].
    Duran-Ferreras E; Duran-Ferreras A
    Rev Neurol; 2011 Mar; 52(6):382-3. PubMed ID: 21387256
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.
    Catafau AM; Tolosa E;
    Mov Disord; 2004 Oct; 19(10):1175-82. PubMed ID: 15390019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Referral practice, reporting standards, and the impact of dopamine transporter scans done in a tertiary hospital.
    Bhattacharjee S; Chalissery AJ; Barry T; O'Sullivan D; O'Connell M; Lynch T
    Neurol India; 2017; 65(6):1264-1270. PubMed ID: 29133699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Performance of the Visual Reading of
    Booij J; Dubroff J; Pryma D; Yu J; Agarwal R; Lakhani P; Kuo PH
    J Nucl Med; 2017 Nov; 58(11):1821-1826. PubMed ID: 28473597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
    Seibyl JP; Kupsch A; Booij J; Grosset DG; Costa DC; Hauser RA; Darcourt J; Bajaj N; Walker Z; Marek K; McKeith I; O'Brien JT; Tatsch K; Tolosa E; Dierckx RA; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1288-96. PubMed ID: 24925885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
    Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
    Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of Inspection Technology of Dopamine Transporter Imaging with ¹²³I-Ioflupane].
    Sato K; Kimura S; Okuyama Y; Nagasawa H; Suzuki M; Iseki E
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2015 Aug; 71(8):670-7. PubMed ID: 26289979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders.
    Manoharan P; Jamieson S; Bury RF
    Clin Radiol; 2007 May; 62(5):463-71. PubMed ID: 17398272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DaT's Awesome: Hawai'i's First Dopamine Transporter (DaT) Nuclear Medicine Study.
    Royston EJ; Kao YE; Nakamura KM
    Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):16-18. PubMed ID: 29164011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0.
    Djang DS; Janssen MJ; Bohnen N; Booij J; Henderson TA; Herholz K; Minoshima S; Rowe CC; Sabri O; Seibyl J; Van Berckel BN; Wanner M
    J Nucl Med; 2012 Jan; 53(1):154-63. PubMed ID: 22159160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.